BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7122911)

  • 1. Inhibition of phospholipase A2 activity by Fluosol, an artificial blood substitute.
    Shakir KM; Williams TJ
    Prostaglandins; 1982 Jun; 23(6):919-27. PubMed ID: 7122911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase A2 activity specific for phosphatidic acid. A possible mechanism for the production of arachidonic acid in platelets.
    Billah MM; Lapetina EG; Cuatrecasas P
    J Biol Chem; 1981 Jun; 256(11):5399-403. PubMed ID: 7240145
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphatidylinositol hydrolysis by phospholipase A2 and C activities in human peripheral blood neutrophils.
    Smith DM; Waite M
    J Leukoc Biol; 1992 Dec; 52(6):670-8. PubMed ID: 1464738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topology of glutathione-insulin transhydrogenase in rat liver microsomes.
    Hern EP; Varandani PT
    Biochim Biophys Acta; 1983 Jul; 732(1):170-8. PubMed ID: 6871188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phospholipases by Met-Leu-Phe-Ile-Leu-Ile-Lys-Arg-Ser-Arg-His-Phe, C terminus of middle-sized tumor antigen.
    Notsu Y; Namiuchi S; Hattori T; Matsuda K; Hirata F
    Arch Biochem Biophys; 1985 Jan; 236(1):195-204. PubMed ID: 2857079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies on fluosol DA administration in acute pancreatitis.
    Ohyanagi H; Ohashi O; Nakayama S; Yamamoto M; Okumura S; Saitoh Y
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):585-94. PubMed ID: 3179491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased phospholipase A2 activity in plasma and liver in uncontrolled diabetes mellitus. A defect in the early steps of prostaglandin synthesis?
    Shakir KM; Reed HL; O'Brian JT
    Diabetes; 1986 Apr; 35(4):403-10. PubMed ID: 3956877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic characterization of Escherichia coli outer membrane phospholipase A using mixed detergent-lipid micelles.
    Horrevoets AJ; Hackeng TM; Verheij HM; Dijkman R; de Haas GH
    Biochemistry; 1989 Feb; 28(3):1139-47. PubMed ID: 2653433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of liver lysosomal acid phospholipase A1.
    Kunze H; Bohn E; Löffler BM
    Eur J Biochem; 1988 Nov; 177(3):591-5. PubMed ID: 3197719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory mechanism of opioid binding to receptor by phospholipase A2.
    Makimura M; Ito Y; Murakoshi Y
    Gen Pharmacol; 1988; 19(5):707-12. PubMed ID: 2850963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fluorocarbon blood substitute on neutrophil phagocytic function.
    Xiao N; Lu XC; Chen HS; Yang ZH; Tian KL
    Zhongguo Yao Li Xue Bao; 1989 Nov; 10(6):537-9. PubMed ID: 2561936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phagocytic activation of human neutrophils by the detergent component of fluosol.
    Ingram DA; Forman MB; Murray JJ
    Am J Pathol; 1992 May; 140(5):1081-7. PubMed ID: 1316083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory aspects of mitochondrial phospholipase A2 from rat liver: effects of proteins, phospholipids and calcium ions.
    Lenting HB; Neys FW; van den Bosch H
    Biochim Biophys Acta; 1988 Jul; 961(1):129-38. PubMed ID: 2968122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of phospholipase A2 released from rat platelets.
    Horigome K; Hayakawa M; Inoue K; Nojima S
    J Biochem; 1987 Mar; 101(3):625-31. PubMed ID: 3597343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid.
    Vadas P; Stefanski E; Pruzanski W
    Life Sci; 1985 Feb; 36(6):579-87. PubMed ID: 3918225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced phospholipase A2 activity in rat plasma, liver, and intestinal mucosa following endotoxin treatment: a possible explanation for the protective effect of indomethacin in endotoxic shock.
    Shakir KM; O'Brian JT; Gartner SL
    Metabolism; 1985 Feb; 34(2):176-82. PubMed ID: 3881649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound 48/80 is a potent inhibitor of phospholipase C and a dual modulator of phospholipase A2 from human platelet.
    Bronner C; Wiggins C; Monté D; Märki F; Capron A; Landry Y; Franson RC
    Biochim Biophys Acta; 1987 Aug; 920(3):301-5. PubMed ID: 3607084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective release of phospholipase A2 and lysophosphatidylserine-specific lysophospholipase from rat platelets.
    Horigome K; Hayakawa M; Inoue K; Nojima S
    J Biochem; 1987 Jan; 101(1):53-61. PubMed ID: 3571210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of insulin release due to inhibition of phospholipase A2 activity.
    Tanaka N; Kagawa S; Murakoso K; Shimizu S; Matsuoka A
    Horm Metab Res; 1983 May; 15(5):255-6. PubMed ID: 6409772
    [No Abstract]   [Full Text] [Related]  

  • 20. Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat.
    Shrewsbury RP; White SG; Pollack GM; Wargin WA
    J Pharm Pharmacol; 1986 Dec; 38(12):883-7. PubMed ID: 2880960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.